Validation of a Remediation Method for Memory Impairments Through Motor Encoding in Patients With Alzheimer's Disease

Recruiting N/A Interventional Study
Alzheimer s Disease Healhty
Ready to participate?

Review the details below, then apply to join this clinical trial.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
In France, over 1.5 million people suffer from mild cognitive impairment, often a precursor to Alzheimer's disease (AD), whose global prevalence could reach 153 million by 2050. With no curative treatment available, maintaining patients' autonomy at home is essential to mitigate the negative effects of institutionalization and reduce economic costs. Non-pharmacological approaches, such as cognitiv…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patient group: Diagnosis of Alzheimer's disease made by one of the consulting physicians-a neurologist and/or geriatrician (Dubois et al., 2014)-at the early stage, presenting with mild memory impairment of which the patient has been informed \- MMSE score of 21 or higher Cont…
Contacts

Céline BORD, MD

(0)4 77 82 88 82

celine.borg@chu-st-etienne.fr

CONTACT

Céline LECLERCQ TRAUTVETTER, CDP

(0)4 77 82 94 27

Celine.LECLERCQTRAUTVETTER@chu-stetienne.fr

CONTACT